Antibodies to intracellular cancer antigens combined with chemotherapy enhance anti-cancer immunity
An international team of scientists in Japan, Switzerland, and the United States has confirmed that combining chemotherapy and immunotherapy in cancer treatment enhances the immune system's ability to find and eliminate cancer ...
Cancer
Feb 13, 2012 |
5 / 5 (1) |
0
New therapy combination prolongs survival in dogs with lymphoma
A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The st ...
Cancer
Feb 07, 2012 |
5 / 5 (2) |
0
A leukemia drug kills cancerous T-cells while sparing normal immunity
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell. This cancer can involve the skin and other organs, and patients often die within three years.
Medical research
Jan 25, 2012 |
4.8 / 5 (4) |
0
|
Novel treatment for skin lymphoma
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are being published today (embargoed for 4 pm) in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer ...
Cancer
Jan 17, 2012 |
5 / 5 (1) |
0
Scientists find genetic key to why some cancer patients don't respond to treatment
(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.
Cancer
Jan 05, 2012 |
5 / 5 (2) |
0
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Cancer
Dec 21, 2011 |
not rated yet |
0
PET technique promises better detection and response assessment for Non-Hodgkin's lymphoma
Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, ...
Cancer
Dec 21, 2011 |
not rated yet |
0
Researchers identify genetic mutation responsible for most cases of Waldenstrom's macroglobulinemia
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom's macroglobulinemia, a rare form of lymphoma that has eluded all previous ...
Cancer
Dec 12, 2011 |
5 / 5 (2) |
0
New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ...
Cancer
Nov 28, 2011 |
5 / 5 (3) |
0
|
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Cancer
Nov 24, 2011 |
not rated yet |
0
Scientists look to immune system to handle follicular lymphoma
University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the biology ...
Cancer
Oct 12, 2011 |
5 / 5 (3) |
0
|
Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman ...
Cancer
Aug 15, 2011 |
not rated yet |
0
|
Researchers’ blood cancer breakthrough
Researchers at the University of Southampton have discovered clues to why many patients do not respond to a standard drug for the blood cancer lymphoma, raising hopes that more effective treatments can be designed.
Cancer
Aug 10, 2011 |
not rated yet |
0
Researchers find way to help donor adult blood stem cells overcome transplant rejection
Findings by UT Southwestern Medical Center researchers may suggest new strategies for successful donor adult stem cell transplants in patients with blood cancers such as leukemia, lymphoma and myeloma.
Medical research
Aug 04, 2011 |
4.5 / 5 (2) |
0
|
New genetic mutations found for non-Hodgkin lymphoma
Scientists at the BC Cancer Agency in British Columbia, Canada and their U.S. collaborators have identified a number of new genetic mutations involved in non-Hodgkin lymphoma, or NHL.
Cancer
Jul 28, 2011 |
5 / 5 (1) |
0
